Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ.

J Clin Psychiatry. 2005 Jun;66(6):686-92.

PMID:
15960560
2.

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.

Hudson JI, Wohlreich MM, Kajdasz DK, Mallinckrodt CH, Watkin JG, Martynov OV.

Hum Psychopharmacol. 2005 Jul;20(5):327-41. Review.

PMID:
15912562
3.

Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.

Hirschfeld RM, Vornik LA.

J Clin Psychiatry. 2004;65 Suppl 4:46-52. Review.

4.

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.

Int J Clin Pract. 2007 Aug;61(8):1337-48. Review.

PMID:
17627710
5.

Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.

Dunner DL, D'Souza DN, Kajdasz DK, Detke MJ, Russell JM.

J Affect Disord. 2005 Jul;87(1):115-9. Review.

PMID:
15967235
6.

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball S, Russell J.

J Psychopharmacol. 2008 Jun;22(4):417-25. doi: 10.1177/0269881108091588.

PMID:
18635722
7.

Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.

Hunziker ME, Suehs BT, Bettinger TL, Crismon ML.

Clin Ther. 2005 Aug;27(8):1126-43. Review.

PMID:
16199241
8.

Sexual side-effects of contemporary antidepressants: review.

Schweitzer I, Maguire K, Ng C.

Aust N Z J Psychiatry. 2009 Sep;43(9):795-808. doi: 10.1080/00048670903107575. Review.

PMID:
19670052
9.

Escitalopram therapy for major depression and anxiety disorders.

Baldwin DS, Reines EH, Guiton C, Weiller E.

Ann Pharmacother. 2007 Oct;41(10):1583-92. Epub 2007 Sep 11. Review.

PMID:
17848424
10.

The effects of agomelatine on sexual function in depressed patients and healthy volunteers.

Montejo A, Majadas S, Rizvi SJ, Kennedy SH.

Hum Psychopharmacol. 2011 Dec;26(8):537-42. doi: 10.1002/hup.1243. Epub 2011 Nov 21. Review.

PMID:
22102540
11.

The effects of antidepressants on sexual functioning in depressed patients: a review.

Ferguson JM.

J Clin Psychiatry. 2001;62 Suppl 3:22-34. Review.

12.

Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.

Cowen PJ, Ogilvie AD, Gama J.

Curr Med Res Opin. 2005 Mar;21(3):345-56. Review.

PMID:
15811202
13.

Sexual side effects of antidepressants.

Rothschild AJ.

J Clin Psychiatry. 2000;61 Suppl 11:28-36. Review.

14.

[Sexual dysfunction with antidepressive agents. Effect of the change to amineptine in patients with sexual dysfunction secondary to SSRI].

Montejo AL, Llorca G, Izquierdo JA, Carrasco JL, Daniel E, Pérez-Sola V, Vicens E, Bousoño M, Sánchez-Iglesias S, Franco M, Cabezudo A, Rubio V, Ortega MA, Puigdellivol M, Domenech JR, Allué B, Sáez C, Mezquita B, Gálvez I, Pacheco L, de Miguel E.

Actas Esp Psiquiatr. 1999 Jan-Feb;27(1):23-34. Review. Spanish.

PMID:
10380144
15.

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

Bymaster FP, Lee TC, Knadler MP, Detke MJ, Iyengar S.

Curr Pharm Des. 2005;11(12):1475-93. Review.

PMID:
15892657
16.

Duloxetine pharmacology: profile of a dual monoamine modulator.

Karpa KD, Cavanaugh JE, Lakoski JM.

CNS Drug Rev. 2002 Winter;8(4):361-76. Review.

17.

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL.

J Clin Psychiatry. 2010 Mar;71(3):270-9. doi: 10.4088/JCP.08r04516blu. Epub 2010 Jan 26. Review.

PMID:
20122371
18.

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials.

Faries DE, Heiligenstein JH, Tollefson GD, Potter WZ.

J Clin Psychopharmacol. 2001 Dec;21(6):561-8. Review.

PMID:
11763002
19.

Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies.

Stein DJ, Davidson J, Seedat S, Beebe K.

Expert Opin Pharmacother. 2003 Oct;4(10):1829-38. Review.

PMID:
14521492
20.

Sexual functioning and SSRIs.

Fava M, Rankin M.

J Clin Psychiatry. 2002;63 Suppl 5:13-6; discussion 23-5. Review.

Supplemental Content

Support Center